MOTS-c (10mg)
Master Regulator of Cellular Energy
1.000.000 ₫
Delivery method:
Single vial
1.000.000 ₫
MOTS pen (10mg/40mg)
1.300.000 ₫
MOTS-c is a 16-amino-acid peptide encoded inside the mitochondrial genome — one of the very few peptides the mitochondria themselves produce as a signalling molecule. It acts as a 'master regulator' of metabolic homeostasis, activating AMPK, increasing insulin sensitivity, driving mitochondrial biogenesis and shifting muscle toward oxidative fiber phenotypes. Human work shows declining MOTS-c levels with age, obesity and type-2 diabetes, and exercise transiently raises circulating MOTS-c. Researched outcomes include improved exercise capacity, fat oxidation, glucose handling and cellular stress resistance — effects that overlap heavily with what endurance training produces at the molecular level. Often paired with SS-31 (membrane repair) and NAD+ (redox currency) in the Mito Stack. Typically dosed 2–3× per week in 8–12 week blocks.
Dosage
Start 5mg twice weekly; after 1 week increase to 5mg three times weekly
Duration of effect
Effects last most of a day (plasma half-life: ~12-24 hours)
See full half-life table →Key Features
- Metabolic regulation
- Enhanced exercise capacity
- Fat oxidation support
- Insulin sensitivity
Includes key details, half-life data, usage notes and research sources.
Usage Instructions
Subcutaneous injection as recommended. Consult a healthcare professional for protocols tailored to your goals.
Research Highlights
- Backed by scientific research
- Manufactured to pharmaceutical standards
- Used in clinical research settings
- Established safety profile
Safety Information
- •Consult your healthcare provider before use
- •Not intended for pregnant or nursing women
- •Store properly according to instructions
- •Report any adverse effects to your healthcare provider
Source: Cell Metabolism - ScienceDirect
Clinical Research
MOTS-c is a 16-amino-acid peptide that regulates insulin sensitivity and metabolic homeostasis, preventing age- and diet-dependent insulin resistance and obesity.
Read full studyAdditional Research
Source: Cataldo et al., Endocrine (2023)
In a human cohort study of breast cancer patients on metformin, circulating MOTS-c levels correlated with metabolic response — confirming MOTS-c functions as a measurable endocrine signal of mitochondrial-metabolic health in humans.
Read full study